Actos News
Most Popular Actos Story
5. Actos - Top 10 Warnings and Recalls
Drug: Actos 2006 sales: $3.05 billion Manufacturer: Takeda Safety concern: “black box;” heart failure Related Articles: > Takeda touts Actos as heart attack-free. Read more...
Latest Headlines
- December 15, 2009
- August 19, 2009
- April 9, 2009
- December 10, 2008
- October 28, 2008
- April 10, 2008
- December 12, 2007
- November 29, 2007
- November 28, 2007
- November 16, 2007
- November 15, 2007
- November 14, 2007
- November 12, 2007
- October 4, 2007
- September 28, 2007
- September 21, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
